How Can Low Dose Naltrexone Be Used for Sjogren’s Syndrome?
Case Report: Fibromyalgia Pain Relief with Low Dose Naltrexone (LDN)
Low Dose Naltrexone for Pain – What Can We Learn From Users?
Real-World Effectiveness and Tolerability of Low Dose Naltrexone to Treat Chronic Pain: A Retrospective Cohort Study of One Pain Physician’s Practice
Journal of Pain Research, Volume 18 Authors: Hannah Aalto, Sara Paul & Virginia McEwen Published 10 December 2025 Volume 2025:18 Pages 6637—6649 https://www.dovepress.com/real-world-effectiveness-and-tolerability-of-low-dose-naltrexone-to-tr-peer-reviewed-fulltext-article-JPR Purpose: Low-dose naltrexone (LDN) is an off-label treatment for chronic pain, with evidence supporting its use mainly consisting of small-scale studies. This retrospective cohort review aimed to contribute to this growing body […]
Evaluation of Low-Dose Naltrexone for Chronic Pain Management
Evaluation of Low-Dose Naltrexone for Chronic Pain Management February 2025 Journal of Pain & Palliative Care Pharmacotherapy Alexa Spargo, Lauren Gonser & Brittany Faley https://www.researchgate.net/publication/388679440_Evaluation_of_Low-Dose_Naltrexone_for_Chronic_Pain_Management Abstract Naltrexone is an opioid antagonist approved by the Food and Drug Administration (FDA) for alcohol use disorder and opioid use disorder. More recently, naltrexone has been used off-label at […]
Co-administration of low-dose-Naltrexone and Carbamazepine remarkedly ameliorate allodynia and cognitive deficit in a rat model of trigeminal neuralgia
Co-administration of low-dose-Naltrexone and Carbamazepine remarkedly ameliorate allodynia and cognitive deficit in a rat model of trigeminal neuralgia Yeganeh Naderi, Monavareh Soti, Masoud Soltani, Yasaman Naderi, Kristi A. Kohlmeier & Mohammad Shabani Scientific Reports volume 15, Article number: 31335 (26th August 2025) https://www.nature.com/articles/s41598-025-14820-4 Abstract The aim of this study was to examine the pain-relieving effects […]
Ultra-Low-Dose Opioid Antagonists Enhance Opioid Analgesia and Reduce Tolerance
Ultra-Low-Dose Opioid Antagonists Enhance Opioid Analgesia and Reduce Tolerance By Hoau-yan Wang 2009, Opiate Receptors and Antagonists https://www.academia.edu/18459676/Ultra_Low_Dose_Opioid_Antagonists_Enhance_Opioid_Analgesia_and_Reduce_Tolerance?email_work_card=view-paper Ultra-low-dose opioid antagonists have been shown to enhance opioid analgesia and attenuate the tolerance to analgesic effects normally seen with chronic opioid administration. This chapter reviews the early work with ultralow-dose opioid antagonists starting with electrophysiological recordings […]
Mark’s Chronic Pain and LDN Journey
Mark’s Chronic Pain and LDN Journey I’d like to share the story of our guest, Mark from Australia, who will be talking to us about chronic pain and LDN. Mark’s pain journey began about 10 years ago after a snowboarding accident which led to slipped discs. Over the past 2 and a half years, […]
Low-Dose Naltrexone for Managing Pain and Autonomic Symptoms in Patients With Dysautonomia
Low-Dose Naltrexone for Managing Pain and Autonomic Symptoms in Patients With Dysautonomia Zapata N, Georgiadi E, Cantrell C, et al. (June 22, 2025) Cureus 17(6): e86538. doi:10.7759/cureus.86538 Abstract Introduction Low-dose naltrexone (LDN) has been studied in recent years as a novel off-label therapy for several conditions under the umbrella of dysautonomia, which is defined as […]
Breakthrough book spotlights the life-changing potential of low dose naltrexone (LDN) for chronic pain and complex conditions
Breakthrough book spotlights the life-changing potential of low dose naltrexone (LDN) for chronic pain and complex conditions The Phoenix Newspaper | Health and Wellbeing 8th June 2025 With millions suffering silently from chronic pain and complex conditions, The LDN Book 4: Case Studies in Chronic Pain (LDN Research Trust) is offering timely and life-changing insights […]